CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Planned sale CFO and Treasurer sold 10,000 shares at $99.36 ($993,600)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Grant or award Director acquired 2,012 shares (grant or award)
- 4 Planned sale See Remarks sold 6,113 shares at $98.82 ($604,087)
- 4 Grant or award See Remarks acquired 8,464 shares (grant or award)
- 4 Planned sale Chief Accounting Officer sold 386 shares at $88.67 ($34,227)
- 4 Grant or award See Remarks acquired 3,301 shares (grant or award)
- 4 Planned sale Chief Business Officer sold 2,118 shares at $88.67 ($187,803)
- 4 Planned sale Chief Business Officer sold 3,684 shares at $82.09 ($302,420)
- 4/A Open-market sale CEO sold 44,484 shares at an average $80.77 ($3,592,856)
- 4 Open-market sale Director sold 13,290 shares at $81.13 ($1,078,218)
- 4 Open-market sale CEO sold 44,484 shares at an average $80.77 ($3,592,856)
- 4 Open-market sale Chief Business Officer sold 14,528 shares at $81.13 ($1,178,657)
- 4 Open-market sale Director sold 7,012 shares at an average $80.75 ($566,200)
Page 9 of 30 · 598 filings